NUVASIVE (NASDAQ:NUVA)
33.80
3.35 (9.02%)
| NUVASIVE (NASDAQ:NUVA) Delayed : |
| Previous Close |
$37.15 |
|
52 Week High |
$45.06 |
|
| Open |
$36.85 |
|
52 Week Low |
$24.17 |
| Day High |
$37.35 |
|
P/E |
177.89 |
| Day Low |
$33.06 |
|
EPS |
$0.19 |
| Volume |
5,546,854 |
|
|
|
| More NUVA Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on NUVA
-
Nov 6, 2009 08:43 AM
NuVasive (NUVA) Appoints Lambert to EVP and CFO; Makes Other Management Changes
-
Nov 3, 2009 09:47 AM
Osiris Therapeutics (OSIR) Achieves $15M Milestone Payment Related to Osteocel Business Sale
-
Oct 28, 2009 07:25 AM
Goldman Sachs Ups Edwards Lifesciences (EW) to Buy, On Product Cycle and Possible Take-Out; NUVA Downgraded
-
Oct 21, 2009 12:52 PM
Canaccord Adams Reiterates a 'Buy' on NuVasive (NUVA), Raises PT
-
Oct 20, 2009 05:45 PM
After-Hours Movers 10/20: IDSA, ZHNE, SNDK, DSCM, SLM, YHOO Higher; TSFG, BNHNA, ISRG, PLCM, NUVA Lower
View All Reports
StreetInsider Reports on NUVA by Category
Comments on recent NUVA articles
Comments on NUVA
No comments are currently available.
on Apr 6, 2008
at 12:56 AM NUVA THIS COMPANY SHOULD BE UPGRADED TO SUPER STRONG BUY! BUY! BUY!
Article: Merriman Curhan Initiates Coverage on NuVasive (NUVA) with a Buy